The global market for intraosseous infusion devices is witnessing a significant surge, with demand expected to skyrocket from USD 4.4 billion in 2023 to an impressive USD 8.6 billion by 2033. This exponential growth trajectory is supported by a robust Compound Annual Growth Rate (CAGR) of 6.9% over the forecast period, highlighting the market’s immense potential and increasing adoption across the globe.
Recent market analysis underscores a substantial rise in the demand for intraosseous infusion devices, driven by advancements in healthcare technologies and a heightened focus on emergency medical care worldwide. As the need for rapid and effective vascular access in critical situations continues to escalate, this market expansion signifies a pivotal shift in medical practices and patient care.
Request A Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1569
The increasing utilization of intraosseous infusion devices in emergency settings is a key factor contributing to this growth. These devices provide a quick and reliable method for administering fluids and medications when traditional intravenous access is challenging or time-consuming. With ongoing advancements in healthcare infrastructure and technology, the adoption of intraosseous infusion devices is expected to expand further, ensuring better patient outcomes and streamlined emergency care.
Intraosseous infusion devices have become indispensable in various medical scenarios, including trauma, cardiac arrest, and severe dehydration, where immediate vascular access is crucial. The growing prevalence of such medical emergencies, coupled with a global focus on enhancing emergency medical services, is propelling the market forward.
As the market continues to evolve, stakeholders are investing in research and development to introduce innovative and efficient intraosseous infusion solutions. This continuous innovation is expected to drive market growth and reinforce the critical role of intraosseous infusion devices in modern healthcare.
Key Takeaways from Intraosseous Infusion Devices Market Study:
- By product, EZ-IO holds the maximum share of 20% in the market in 2021, expanding at 6.4% CAGR during the forecast period.
- By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
- By technology, the automatic segment will account for more than 50.8% of the market share in 2021.
- By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.
“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst
Request Customization Available: https://www.futuremarketinsights.com/customization-available/rep-gb-1569
Who is winning?
Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.
- Cook Medical: Every medical profession we offer has two common threads: patients who want to be healthy and clinicians who desire more user-friendly tools. As a result, we devote significant resources to designing, manufacturing, and delivering a differentiated range of minimally invasive medical devices to healthcare systems worldwide.
- Becton Dickinson and Company: With a product line that fulfils the needs of patients, we want to increase physician satisfaction while also assisting hospitals and surgery centres in improving results and lowering expenses. BD has refined surgical instruments and led to improved results for more than a century. with a substantial portfolio and a track record of supplying high-quality items
The key market players covered by FMI include:
- Pyng Medical Corp.
- Biopsybell
- Cook Medical Incorporated
- PAVmed
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Company
- SAM Medical
- Cardinal Health, Inc
Intraosseous Infusion Devices – Market by Category:
Product:
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
By Route of Administration:
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
By Technology:
- Manual
- Automatic
- Impact Driven
- Power Drill
A Comprehensive Full Report: https://www.futuremarketinsights.com/checkout/1569
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
